Regeneron Pharmaceuticals Inc. Stock Slips 4.1%, Underperforms Competitors

Dow Jones2025-03-26

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. slid 4.1% to $634.14 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.2% to 5,776.65 and the Dow Jones Industrial Average rising 0.0% to 42,587.50.

Regeneron Pharmaceuticals Inc. closed 47.6% below its 52-week high of $1,211.20, which the company reached on August 27th.

The stock underperformed when compared to some of its competitors, as Amgen Inc. fell 2.4% to $306.86, Moderna Inc. fell 0.9% to $33.85, and Gilead Sciences Inc. rose 1.08% to $107.89.

Trading volume totaled 848,623, compared to the 50-day average of 967,305.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

March 25, 2025 16:33 ET (20:33 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2522838394?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-26 04:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2522838394","market":"sh","top_or_hot":-1,"title":"Regeneron Pharmaceuticals Inc. Stock Slips 4.1%, Underperforms Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Regeneron Pharmaceuticals Inc. slid 4.1% to $634.14 on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index rising 0.2% to 5,776.65 and the Dow Jones Industrial Average rising 0.0% to 42,587.50. \n</p>\n<p>\n     Regeneron Pharmaceuticals Inc. closed 47.6% below its 52-week high of $1,211.20, which the company reached on August 27th. \n</p>\n<p>\n     The stock underperformed when compared to some of its competitors, as Amgen Inc. fell 2.4% to $306.86, Moderna Inc. fell 0.9% to $33.85, and Gilead Sciences Inc. rose 1.08% to $107.89. \n</p>\n<p>\n     Trading volume totaled 848,623, compared to the 50-day average of 967,305. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 25, 2025 16:33 ET (20:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron Pharmaceuticals Inc. Stock Slips 4.1%, Underperforms Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron Pharmaceuticals Inc. Stock Slips 4.1%, Underperforms Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-26 04:33</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Regeneron Pharmaceuticals Inc. slid 4.1% to $634.14 on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index rising 0.2% to 5,776.65 and the Dow Jones Industrial Average rising 0.0% to 42,587.50. \n</p>\n<p>\n     Regeneron Pharmaceuticals Inc. closed 47.6% below its 52-week high of $1,211.20, which the company reached on August 27th. \n</p>\n<p>\n     The stock underperformed when compared to some of its competitors, as Amgen Inc. fell 2.4% to $306.86, Moderna Inc. fell 0.9% to $33.85, and Gilead Sciences Inc. rose 1.08% to $107.89. \n</p>\n<p>\n     Trading volume totaled 848,623, compared to the 50-day average of 967,305. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 25, 2025 16:33 ET (20:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REGN","symbol_name":"再生元制药公司","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2522838394","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522838394","pubTimestamp":1742934780,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc. slid 4.1% to $634.14 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.2% to 5,776.65 and the Dow Jones Industrial Average rising 0.0% to 42,587.50.Regeneron Pharmaceuticals Inc. closed 47.6% below its 52-week high of $1,211.20, which the company reached on August 27th.The stock underperformed when compared to some of its competitors, as Amgen Inc. fell 2.4% to $306.86, Moderna Inc. fell 0.9% to $33.85, and Gilead Sciences Inc. rose 1.08% to $107.89.Trading volume totaled 848,623, compared to the 50-day average of 967,305.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"REGN":"再生元制药公司"},"translate_title":"再生元制药股价下跌4.1%，表现逊于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REGN":1},"content_text":"This article was automatically generated by Dow Jones using technology from Automated Insights. \n\n\n     Shares of Regeneron Pharmaceuticals Inc. slid 4.1% to $634.14 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.2% to 5,776.65 and the Dow Jones Industrial Average rising 0.0% to 42,587.50. \n\n\n     Regeneron Pharmaceuticals Inc. closed 47.6% below its 52-week high of $1,211.20, which the company reached on August 27th. \n\n\n     The stock underperformed when compared to some of its competitors, as Amgen Inc. fell 2.4% to $306.86, Moderna Inc. fell 0.9% to $33.85, and Gilead Sciences Inc. rose 1.08% to $107.89. \n\n\n     Trading volume totaled 848,623, compared to the 50-day average of 967,305. \n\n\n  Data source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2025 16:33 ET (20:33 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2522838394","isCrawlerRequest":true}